Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Nordic Nanovector News

    0,0978 € -1,61% -0,0016 €
    18.04.24 12:29:57 Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1H64K
    ISIN: NO0010597883
    Typ: Aktie

    Nordic Nanovector News

    01.07.21 - PR Newswire
    Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer
    Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer PR Newswire
    01.07.21 - PR Newswire
    Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer
    Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer PR Newswire
    22.06.21 - PR Newswire
    Nordic Nanovector ASA: Share capital increase registered
    Nordic Nanovector ASA: Share capital increase registered PR Newswire
    22.06.21 - PR Newswire
    Nordic Nanovector ASA: Share capital increase registered
    Nordic Nanovector ASA: Share capital increase registered PR Newswire
    22.06.21 - PR Newswire
    Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
    Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PR Newswire
    22.06.21 - PR Newswire
    Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
    Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Increase of share capital
    Nordic Nanovector ASA: Increase of share capital PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Increase of share capital
    Nordic Nanovector ASA: Increase of share capital PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Increase of share capital
    Nordic Nanovector ASA: Increase of share capital PR Newswire
    18.06.21 - PR Newswire
    Nordic Nanovector ASA: Increase of share capital
    Nordic Nanovector ASA: Increase of share capital PR Newswire
    02.06.21 - PR Newswire
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
    02.06.21 - PR Newswire
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
    Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
    26.05.21 - PR Newswire
    Nordic Nanovector ASA: Results for the First Quarter 2021
    Nordic Nanovector ASA: Results for the First Quarter 2021 PR Newswire
    26.05.21 - PR Newswire
    Nordic Nanovector ASA: Results for the First Quarter 2021
    Nordic Nanovector ASA: Results for the First Quarter 2021 PR Newswire
    25.05.21 - PR Newswire
    Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma
    Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma PR Newswire
    25.05.21 - PR Newswire
    Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma
    Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma PR Newswire
    20.05.21 - PR Newswire
    Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast
    Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast PR Newswire
    20.05.21 - PR Newswire
    Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast
    Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast PR Newswire

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »